Verrica Pharmaceuticals Inc. (VRCA) shareholders
Close on Nov 17, 2026Market cap $53.94MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Paul B Manning Joint filing with BKB Growth Investments, LLC (20.90%) | 8,056,031 | 49.90% | 13D (active) amendment | Nov 25, 2025 |
| Caligan Partners LP Joint filing with David Johnson (9.99%) | 6,503,054 | 9.99% | 13D (active) | Nov 23, 2025 |
| David Johnson Joint filing with Caligan Partners LP (9.99%) | 6,503,054 | 9.99% | 13D (active) amendment | Dec 26, 2025 |
| Perceptive Advisors LLC Joint filing with Joseph Edelman (5.10%), Perceptive Life Sciences Master Fund, Ltd. (5.10%) | 4,731,150 | 5.10% | 13G (passive) amendment | Dec 31, 2024 |
| Affinity Asset Advisors, LLC Joint filing with Michael Cho (5.50%) | 884,172 | 5.50% | 13G (passive) amendment | Jan 22, 2026 |
| Affinity Healthcare Fund, LP Joint filing with Affinity Asset Advisors, LLC (5.47%) | 884,172 | 5.47% | 13G (passive) | Nov 25, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of VRCA | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Caligan Partners LP | 923,910 | 5.38% | $5.65M | – | 0.27% |
| Cannell Capital LLC | 783,923 | 4.56% | $4.80M | +98,800 | 3.22% |
| Affinity Asset Advisors, LLC | 707,338 | 4.12% | $4.33M | – | 0.20% |
| Velan Capital Investment Management LP | 471,559 | 2.75% | $2.89M | – | 1.76% |
| Armistice Capital, LLC | 426,304 | 2.48% | $2.61M | −91,877 | 0.03% |
| Boothbay Fund Management, LLC | 280,734 | 1.63% | $1.72M | – | 0.02% |
| Vanguard Capital Management LLC | 279,310 | 1.63% | $1.71M | +90,552 | 0.00% |
| Mariner, LLC | 207,230 | 1.21% | $1.27M | +182,686 | 0.00% |
| Geode Capital Management, LLC | 138,160 | 0.80% | $845.66K | −757 | 0.00% |
| BlackRock, Inc. | 74,344 | 0.43% | $454.99K | +35,791 | 0.00% |
| Vanguard Fiduciary Trust Co | 70,173 | 0.41% | $429.46K | +5,072 | 0.00% |
| Two Sigma Investments, LP | 40,825 | 0.24% | $249.85K | −9,837 | 0.00% |
| State Street Corp | 28,916 | 0.17% | $176.97K | – | 0.00% |
| Northern Trust Corp | 26,996 | 0.16% | $165.22K | −4,584 | 0.00% |
| DAFNA Capital Management LLC | 23,750 | 0.14% | $145.35K | −129,962 | 0.03% |
| Jane Street Group, LLC | 23,654 | 0.14% | $144.76K | −25,557 | 0.00% |
| Verdad Advisers, LP | 23,069 | 0.13% | $141.18K | +10,971 | 0.14% |
| Renaissance Technologies LLC | 21,769 | 0.13% | $133.23K | −10,591 | 0.00% |
| Legacy Trust | 16,584 | 0.10% | $101.49K | −650 | 0.02% |
| Fifth Third Bancorp | 14,000 | 0.08% | $85.68K | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 43 | 5M | 27.1% | 9 / 7 | 11 / 5 | 0M | 1M |
| Q1 2026 | 39 | 5M | 27.8% | 6 / 10 | 7 / 16 | 1M | 1M |
| Q4 2025 | 50 | 5M | 30.2% | 22 / 5 | 10 / 5 | 3M | 0M |
| Q3 2025 | 33 | 2M | 14.4% | 33 / 0 | 0 / 5 | 2M | 0M |
| Q2 2025 | 5 | 0M | 0.1% | 5 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
15 funds held VRCA in Q2 2026, 74% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of VRCA | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 143,141 | 0.83% | $876.02K | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 135,465 | 0.79% | $829.05K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 61,808 | 0.36% | $356.01K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 33,630 | 0.20% | $205.82K | 0.01% | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 20,514 | 0.12% | $118.16K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 17,055 | 0.10% | $98.24K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 10,929 | 0.06% | $62.95K | 0.00% | May 31, 2026 |
| Dimensional U.S. Small Cap ETF | 7,373 | 0.04% | $38.49K | 0.00% | Jul 31, 2026 |
| 1290 VT Micro Cap Portfolio | 2,195 | 0.01% | $13.43K | 0.01% | Jun 30, 2026 |
| U.S. Micro Cap Portfolio | 2,088 | 0.01% | $10.90K | 0.00% | Jul 31, 2026 |
| JNL/DFA U.S. Small Cap Fund | 1,982 | 0.01% | $12.13K | 0.00% | Jun 30, 2026 |
| Dimensional US Core Equity 1 ETF | 1,645 | 0.01% | $8.59K | 0.00% | Jul 31, 2026 |
| Dimensional U.S. Core Equity 2 ETF | 800 | 0.00% | $4.18K | 0.00% | Jul 31, 2026 |
| Avantis Total Equity Markets ETF | 481 | 0.00% | $2.77K | 0.00% | May 31, 2026 |
| Vanguard Balanced Index Fund | 262 | 0.00% | $1.60K | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Jayson Rieger | CEO and President, Director | 207,838 | 1.21% | Aug 18, 2026 |
| Ted White | PRESIDENT AND CEO, Director | 278,789 | 1.62% | Feb 6, 2025 |
| John J. Kirby | Interim CFO | 23,962 | 0.14% | Aug 18, 2026 |
| Noah L. Rosenberg | CMO | 8,587 | 0.05% | Aug 18, 2026 |
| David Zawitz | Chief Operating Officer | 27,000 | 0.16% | Aug 18, 2026 |
| Christopher G. Hayes | CHIEF LEGAL OFFICER | 176,458 | 1.03% | Mar 18, 2025 |
| Joe Bonaccorso | CHIEF COMMERCIAL OFFICER | 187,738 | 1.09% | Feb 6, 2025 |
| Terry Kohler | CHIEF FINANCIAL OFFICER | 125,000 | 0.73% | Feb 6, 2025 |
| Gary Goldenberg | Chief Medical Officer | 120,110 | 0.70% | Feb 6, 2025 |
| Diem Nguyen | Director | 100 | 0.00% | Jun 9, 2026 |
| Gavin Corcoran | Director | 20 | 0.00% | Jun 9, 2026 |
| Lawrence Eichenfield | Director | – | – | Jun 9, 2026 |
| Mark A. Prygocki Sr | Director | – | – | Jun 9, 2026 |
| Charles Frantzreb | Director | – | – | Dec 30, 2025 |
| Paul B. Manning | Director, 10% owner | 7,395,748 | 43.05% | Nov 25, 2025 |
| John A. Stalfort III | Director | 1,873,800 | 10.91% | Nov 26, 2024 |
| BKB Growth Investments, LLC | 10% owner | 3,348,372 | 19.49% | Feb 2, 2026 |
| Partners LP Caligan | – | – | – | Dec 30, 2025 |
| David Edward Johnson | – | 923,910 | 5.38% | Dec 30, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| John J. Kirby Interim CFO | Aug 18, 2026 | Buy | +5,000 | $4.93 | $24.65K | 23,962 |
| Noah L. Rosenberg CMO | Aug 18, 2026 | Buy | +2,030 | $4.92 | $9.99K | 8,587 |
| David Zawitz Chief Operating Officer | Aug 17, 2026 | Buy | +6,000 | $4.98 | $29.88K | 27,000 |
| Noah L. Rosenberg CMO | Aug 17, 2026 | Buy | +4,200 | $4.91 | $20.62K | 6,557 |
| Jayson Rieger CEO and President, Director | Aug 17, 2026 | Buy | +5,000 | $4.91 | $24.55K | 207,593 |
| Jayson Rieger CEO and President, Director | Aug 14, 2026 | Buy | +20,000 | $5.06 | $101.20K | 202,593 |
| John J. Kirby Interim CFO | Dec 23, 2025 | Award | +10,000 | – | – | 18,962 |
| Noah L. Rosenberg CMO | Nov 25, 2025 | Buy | +2,357 | $4.24 | $9.99K | 2,357 |
| John J. Kirby Interim CFO | Nov 25, 2025 | Buy | +3,536 | $4.24 | $14.99K | 8,962 |
| Jayson Rieger CEO and President, Director | Nov 25, 2025 | Buy | +94,311 | $4.24 | $399.88K | 182,593 |
| David Zawitz Chief Operating Officer | Nov 25, 2025 | Buy | +10,000 | $4.24 | $42.40K | 21,000 |
| Paul B. Manning Director, 10% owner | Nov 25, 2025 | Buy | +2,750,762 | $4.24 | $11.66M | 3,348,372 |
| Paul B. Manning Director, 10% owner | Nov 25, 2025 | Buy | +1,375,380 | $4.24 | $5.83M | 3,958,189 |
| Christopher G. Hayes CHIEF LEGAL OFFICER | Mar 17, 2025 | Sale | −4,315 | $0.65 | $2.80K | 176,458 |
| Jayson Rieger CEO and President, Director | Nov 26, 2024 | Gift | +50,000 | – | – | 882,826 |
| Paul B. Manning Director, 10% owner | Nov 26, 2024 | Gift | −450,000 | – | – | 25,828,094 |
| John A. Stalfort III Director | Nov 26, 2024 | Gift | +50,000 | – | – | 1,873,800 |
| Jayson Rieger CEO and President, Director | Nov 22, 2024 | Buy | +280,898 | – | – | 832,826 |
| Paul B. Manning Director, 10% owner | Nov 22, 2024 | Buy | +18,426,966 | – | – | 26,278,094 |
| Paul B. Manning Director, 10% owner | Nov 22, 2024 | Buy | +4,494,382 | – | – | 5,976,101 |
| John A. Stalfort III Director | Nov 22, 2024 | Buy | +1,123,595 | – | – | 1,823,800 |
| John J. Kirby Interim CFO | Nov 6, 2024 | Award | +54,267 | – | – | 54,267 |
| Paul B. Manning Director, 10% owner | Sep 19, 2024 | Gift | −2,675,611.25 | – | – | 0 |
| Paul B. Manning Director, 10% owner | Sep 19, 2024 | Gift | +891,870.41 | – | – | 891,870 |
| Paul B. Manning Director, 10% owner | Sep 19, 2024 | Gift | +891,870.42 | – | – | 891,870 |
| Paul B. Manning Director, 10% owner | Sep 19, 2024 | Gift | +891,870.42 | – | – | 891,870 |
| Joe Bonaccorso CHIEF COMMERCIAL OFFICER | Aug 27, 2024 | Sale | −8,993 | $2.46 | $22.12K | 73,114 |
| Gary Goldenberg Chief Medical Officer | Aug 27, 2024 | Sale | −3,601 | $2.46 | $8.86K | 94,261 |
| Ted White PRESIDENT AND CEO, Director | Aug 27, 2024 | Sale | −9,021 | $2.46 | $22.19K | 215,967 |
| Christopher G. Hayes CHIEF LEGAL OFFICER | Aug 27, 2024 | Sale | −9,530 | $2.46 | $23.44K | 105,773 |
| Terry Kohler CHIEF FINANCIAL OFFICER | Aug 27, 2024 | Sale | −7,899 | $2.46 | $19.43K | 44,697 |
| Joe Bonaccorso CHIEF COMMERCIAL OFFICER | Aug 26, 2024 | Sale | −24,709 | $2.66 | $65.73K | 82,107 |
| Gary Goldenberg Chief Medical Officer | Aug 26, 2024 | Sale | −9,888 | $2.66 | $26.30K | 97,862 |
| Ted White PRESIDENT AND CEO, Director | Aug 26, 2024 | Sale | −24,979 | $2.66 | $66.44K | 224,988 |
| Christopher G. Hayes CHIEF LEGAL OFFICER | Aug 26, 2024 | Sale | −26,183 | $2.66 | $69.65K | 115,303 |
| Terry Kohler CHIEF FINANCIAL OFFICER | Aug 26, 2024 | Sale | −21,820 | $2.66 | $58.04K | 52,596 |
| Joe Bonaccorso CHIEF COMMERCIAL OFFICER | Jul 23, 2024 | Sale | −115 | $6.98 | $803 | 106,816 |
| Christopher G. Hayes CHIEF LEGAL OFFICER | Jul 23, 2024 | Sale | −91 | $6.98 | $635 | 141,486 |
| Ted White PRESIDENT AND CEO, Director | Jul 23, 2024 | Sale | −154 | $6.98 | $1.07K | 249,967 |
| Gary Goldenberg Chief Medical Officer | Jul 23, 2024 | Sale | −86 | $6.98 | $600 | 107,750 |
| Joe Bonaccorso CHIEF COMMERCIAL OFFICER | Jul 22, 2024 | Sale | −25,461 | $7.06 | $179.75K | 106,931 |
| Christopher G. Hayes CHIEF LEGAL OFFICER | Jul 22, 2024 | Sale | −21,649 | $7.06 | $152.84K | 141,577 |
| Ted White PRESIDENT AND CEO, Director | Jul 22, 2024 | Sale | −32,469 | $7.06 | $229.23K | 250,121 |
| Gary Goldenberg Chief Medical Officer | Jul 22, 2024 | Sale | −18,421 | $7.06 | $130.05K | 107,836 |
| Joe Bonaccorso CHIEF COMMERCIAL OFFICER | Mar 15, 2024 | Award | +40,000 | – | – | 132,392 |
| Ted White PRESIDENT AND CEO, Director | Mar 15, 2024 | Award | +112,500 | – | – | 282,590 |
| Gary Goldenberg CHIEF MEDICAL OFFICER | Mar 15, 2024 | Award | +40,000 | – | – | 126,257 |
| Terry Kohler CHIEF FINANCIAL OFFICER | Mar 15, 2024 | Award | +40,000 | – | – | 74,416 |
| Christopher G. Hayes CHIEF LEGAL OFFICER | Mar 15, 2024 | Award | +40,000 | – | – | 163,226 |
| Joseph Edelman 10% owner | Dec 29, 2023 | Buy | +115,774 | $7.24 | $838.20K | 7,099,182 |
| Joseph Edelman 10% owner | Dec 28, 2023 | Buy | +126,116 | $7.08 | $892.90K | 6,983,408 |
| Joseph Edelman 10% owner | Dec 27, 2023 | Buy | +79,726 | $7.20 | $574.03K | 6,857,292 |
| Advisors Llc Perceptive 10% owner | Dec 26, 2023 | Buy | +54,652 | $6.49 | $354.69K | 6,777,566 |
| Advisors Llc Perceptive 10% owner | Dec 22, 2023 | Buy | +250,000 | $6.67 | $1.67M | 6,722,914 |
| Advisors Llc Perceptive 10% owner | Dec 21, 2023 | Buy | +200,000 | $6.17 | $1.23M | 6,472,914 |
| Advisors Llc Perceptive 10% owner | Dec 19, 2023 | Buy | +277,008 | $5.36 | $1.48M | 6,272,914 |
| Advisors Llc Perceptive 10% owner | Dec 18, 2023 | Buy | +456,923 | $5.41 | $2.47M | 5,995,906 |
| Advisors Llc Perceptive 10% owner | Dec 15, 2023 | Buy | +500,000 | $5.97 | $2.99M | 5,538,983 |
| Ted White President and CEO, Director | Nov 15, 2023 | Sale | −11,558 | $2.97 | $34.33K | 170,090 |
| Joe Bonaccorso Chief Commercial Officer | Nov 15, 2023 | Sale | −11,266 | $2.97 | $33.46K | 92,392 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Verrica Pharmaceuticals's stock actually held short. Settlement fails (shares not delivered on time) peaked at 70,000 shares on Aug 31, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Gary Goldenberg Officer | Aug 26, 2024 | 14,000 | $37.00K | Aug 26, 2024 | RSU Vesting |
| Joe Bonaccorso Officer | Aug 26, 2024 | 34,000 | $90.10K | Aug 26, 2024 | RSU Vesting |
| Ted White Officer | Aug 26, 2024 | 34,000 | $90.10K | Aug 26, 2024 | RSU Vesting |
| Christopher G. Hayes Officer | Aug 26, 2024 | 36,000 | $94.30K | Aug 26, 2024 | RSU Vesting |
| Terry Kohler Officer | Aug 26, 2024 | 30,000 | $79.50K | Aug 26, 2024 | RSU Vesting |
| Christopher G. Hayes Officer | Jul 22, 2024 | 21,971 | $153.09K | Jul 22, 2024 | RSU Vesting |
| Joe Bonaccorso Officer | Jul 22, 2024 | 25,840 | $180.05K | Jul 22, 2024 | RSU Vesting |
| Ted White Officer | Jul 22, 2024 | 32,953 | $229.63K | Jul 22, 2024 | RSU Vesting |
| Gary Goldenberg Officer | Jul 22, 2024 | 18,695 | $130.25K | Jul 22, 2024 | RSU Vesting |
| Joe Bonaccorso Officer | Nov 16, 2023 | 32,943 | $96.52K | Nov 14, 2023 | RSU Vesting |
| Gary Goldenberg Officer | Nov 15, 2023 | 8,879 | $26.02K | Nov 14, 2023 | RSU Vesting |
| Ted White Officer, Director | Nov 15, 2023 | 33,798 | $99.03K | Nov 14, 2023 | RSU Vesting |
| Joe Bonaccorso Officer | Nov 15, 2023 | 32,943 | $96.52K | Nov 14, 2023 | RSU Vesting |
| Christopher G. Hayes Officer | Nov 15, 2023 | 33,798 | $99.03K | Nov 14, 2023 | RSU Vesting |
| Terry Kohler Officer | Nov 15, 2023 | 28,167 | $82.53K | Nov 14, 2023 | RSU Vesting |
See a number that looks wrong?